search
Blood Work
Trends
- 1University of Arizona scientists develop drug candidate for vascular dementia●Vascular dementia has no approved treatments. U of A scientists hope to change that with an inflammation-fighting drug candidate.
University of Arizona scientists are working on an inflammation-fighting drug candidate aimed at vascular dementia, a condition that currently has no approved treatments. The research, announced by the university, targets the inflammation believed to drive blood vessel-related cognitive decline. If successful, the candidate could become the first approved therapy for a disease affecting millions of older adults worldwide.
- 2
Charles Kelley, member of country trio Lady A, has announced he has been diagnosed with a rare blood cancer at age 45, saying he intends to keep working through treatment. The news comes alongside a string of other cancer headlines, including Will Reeve reflecting on his late parents after revealing his own diagnosis, research on infections linked to millions of annual cancer cases, and trial results showing radiosurgery improves survival in lung cancer that has spread to the brain.
- 3NIH grants $11.7 million for blood cancer inflammation research●$11.7 million from NIH supports research on inflammation in blood cancers
The National Institutes of Health has awarded $11.7 million to researchers at WashU Medicine to study the role of inflammation in blood cancers. The funding will support investigations into how inflammatory processes drive the development and progression of these diseases, work that could inform new treatment approaches. The announcement highlights continued federal investment in cancer research.